Concure Oncology revealed on Friday the addition of Scott Armstrong to its board of directors.
As a member of the company's board, Armstrong supports the advancement of Breast Microseed Treatment as well as continue his advocacy for patient-centric care.
Most recently, Armstrong has served as president and CEO of Group Health Cooperative, anot-for-profit health plan company, positions he has held for 12 years.
Previously at Group Health, Armstrong has worked as VP of Network Services, executive VP/chief administrative officer as well as executive VP/chief operating officer.
Anixa Biosciences transfers breast cancer vaccine IND from Cleveland Clinic
RedHill Biopharma reports positive opaganib data in venetoclax-resistant CLL
Genmab completes tender offer for Merus and opens subsequent offering period
NanOlogy launches drug development program for diffuse intrinsic pontine glioma treatment
Privo Technologies doses first patient in first-in-human clinical trial of PRV131
Senhwa Biosciences signs clinical supply agreement with BeOne Medicines
D3 Bio completes USD108m Series B financing round
Champions Oncology expands bioanalytical services with new technology and leadership
Poolbeg Pharma trial to feature in major CRS research programme